GOLEMBIEWSKI MICHAEL JOSEPH (Chief Financial Officer) received a stock award from SEELOS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/4/2022ACC: 0001136261-22-000155
Officer· Chief Financial Officer
Since Sep 2021
+12.50K
Net shares
Net buyer
$11.3K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
12.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12.50K
Price / share
$0.90
Trade value
$11.26K
% of position
18.9%
2/28/2022
65.99K→78.49K
Total
Net shares
+12.50K
Net value
$11.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/28/2022 | A · Award | +12.50K | $0.90 | $11.26K | 18.9% | 65.99K | 78.49K |
| Total | +12.50K | $11.26K | ||||||
Derivative Transactions0
No derivative transactions reported